Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock ...Middle East

WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved...

Hence then, the article about spyre therapeutics announces pricing of 200 million public offering of common stock was published today ( Tuesday 19/11/2024 - 05:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock )

Also on site :

• Instructure strikes deal with hackers who breached it twice .. TechCrunch
• AI voice startup Vapi hits $500M valuation after winning Amazon Ring over 40 rivals
• SAP CEO: the AI race is being fought in the wrong place